HUE053233T2 - Bilasztint és mometanzont tartalmazó vizes készítmények - Google Patents

Bilasztint és mometanzont tartalmazó vizes készítmények

Info

Publication number
HUE053233T2
HUE053233T2 HUE18786334A HUE18786334A HUE053233T2 HU E053233 T2 HUE053233 T2 HU E053233T2 HU E18786334 A HUE18786334 A HU E18786334A HU E18786334 A HUE18786334 A HU E18786334A HU E053233 T2 HUE053233 T2 HU E053233T2
Authority
HU
Hungary
Prior art keywords
bilastine
mometasone
aqueous compositions
compositions
aqueous
Prior art date
Application number
HUE18786334A
Other languages
English (en)
Inventor
Herrero Gonzalo Hernandez
Gorostiza Ana Gonzalo
Dominguez Neftali Garcia
Arce Arturo Zazpe
Poladura Pablo Moran
Garcia Tania Gonzalez
Original Assignee
Faes Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Farma Sa filed Critical Faes Farma Sa
Publication of HUE053233T2 publication Critical patent/HUE053233T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HUE18786334A 2017-10-16 2018-10-15 Bilasztint és mometanzont tartalmazó vizes készítmények HUE053233T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17382686 2017-10-16

Publications (1)

Publication Number Publication Date
HUE053233T2 true HUE053233T2 (hu) 2021-06-28

Family

ID=60262869

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18786334A HUE053233T2 (hu) 2017-10-16 2018-10-15 Bilasztint és mometanzont tartalmazó vizes készítmények

Country Status (23)

Country Link
US (1) US11642309B2 (hu)
EP (1) EP3681475B1 (hu)
JP (1) JP2020536972A (hu)
KR (1) KR20200125923A (hu)
CN (1) CN111526869A (hu)
AU (1) AU2018353360B2 (hu)
BR (1) BR112020007569A2 (hu)
CA (1) CA3079303A1 (hu)
CO (1) CO2020005939A2 (hu)
DK (1) DK3681475T3 (hu)
EA (1) EA202090965A1 (hu)
ES (1) ES2858573T3 (hu)
HR (1) HRP20210260T1 (hu)
HU (1) HUE053233T2 (hu)
IL (1) IL273967A (hu)
LT (1) LT3681475T (hu)
MA (1) MA50247B1 (hu)
MX (1) MX2020003834A (hu)
PL (1) PL3681475T3 (hu)
PT (1) PT3681475T (hu)
SG (1) SG11202003384XA (hu)
TW (1) TW201922250A (hu)
WO (1) WO2019076798A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201918617D0 (en) * 2019-12-17 2020-01-29 Reckitt Benckiser Health Ltd Personal lubricant composition

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048109B1 (es) 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
DE4426709A1 (de) 1994-07-20 1996-01-25 Schering Ag Steroidale Sexualhormone enthaltende feste Arzneiformen
ES2124167B1 (es) 1996-06-04 1999-09-16 Espanola Prod Quimicos Nuevos derivados del bencimidazol con actividad antihistaminica.
FR2780901B1 (fr) * 1998-07-09 2000-09-29 Coletica Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
GB0312148D0 (en) * 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
US20060045850A1 (en) 2004-08-30 2006-03-02 Qpharma, Llc Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
WO2007005491A1 (en) 2005-06-30 2007-01-11 Bristol-Myers Squibb Pharma Company Hydrazide conjugates as imaging agents
WO2007047253A2 (en) 2005-10-11 2007-04-26 Eastman Chemical Company Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
EP1894559A1 (en) 2006-09-01 2008-03-05 PARI Pharma GmbH Means to solubilise steroids for inhalation
CN101273993A (zh) * 2007-03-27 2008-10-01 北京亚欣保诚医药科技有限公司 糠酸莫米松溶液型液体制剂
EP2173169B1 (en) * 2007-06-28 2014-05-21 CyDex Pharmaceuticals, Inc. Nasal delivery of aqueous corticosteroid solutions
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
CN101756998A (zh) * 2008-11-28 2010-06-30 天津金耀集团有限公司 采用环糊精包合糠酸莫米松的鼻用药物组合物
CN201373609Y (zh) 2009-03-13 2009-12-30 潘戈 太阳能集热器箱体
EP2437743A4 (en) 2009-06-05 2012-11-28 Aciex Therapeutics Inc OPHTHALMIC FORMULATIONS OF FLUTICASONE AND METHODS OF USE
KR101304341B1 (ko) 2011-09-19 2013-09-11 한미약품 주식회사 코르티코스테로이드, 항히스타민제 및 β-사이클로덱스트린을 포함하는, 안정성이 개선된 약학 조성물
US9629847B2 (en) 2011-11-23 2017-04-25 Michael Leighton Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
CN103736098A (zh) * 2013-12-27 2014-04-23 于运红 一种含有比拉斯汀及糠酸莫米松的鼻内给药用药物组合物
CN103784462A (zh) * 2014-02-25 2014-05-14 宋俊智 包含比拉斯汀及甾族化合物的药物制剂
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
WO2016141219A1 (en) 2015-03-05 2016-09-09 Cosmederm Bioscience, Inc. Strontium based compositions and formulations for pain, pruritus, and inflammation
EP3323173B8 (en) * 2015-07-15 2020-10-07 TE Connectivity Services GmbH Conductive bar with annular portion to accommodate test plug
EP3170816A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds

Also Published As

Publication number Publication date
BR112020007569A2 (pt) 2020-09-24
EP3681475A1 (en) 2020-07-22
JP2020536972A (ja) 2020-12-17
IL273967A (en) 2020-05-31
DK3681475T3 (da) 2021-02-01
EP3681475B1 (en) 2020-12-09
US20210186869A1 (en) 2021-06-24
AU2018353360A1 (en) 2020-05-07
PL3681475T3 (pl) 2021-07-05
CA3079303A1 (en) 2019-04-25
AU2018353360B2 (en) 2021-04-01
WO2019076798A1 (en) 2019-04-25
MX2020003834A (es) 2020-08-06
PT3681475T (pt) 2021-03-08
CO2020005939A2 (es) 2020-10-30
ES2858573T3 (es) 2021-09-30
LT3681475T (lt) 2021-02-25
SG11202003384XA (en) 2020-05-28
TW201922250A (zh) 2019-06-16
CN111526869A (zh) 2020-08-11
US11642309B2 (en) 2023-05-09
MA50247B1 (fr) 2021-02-26
KR20200125923A (ko) 2020-11-05
EA202090965A1 (ru) 2020-07-22
MA50247A (fr) 2020-07-22
HRP20210260T1 (hr) 2021-04-02

Similar Documents

Publication Publication Date Title
HK1251922A1 (zh) 抗微生物組合物及其用途
IL271275A (en) Preparations containing coronas and their uses
SI3580561T1 (sl) Metode, osnovane na hla, in njihove sestave ter uporabe
GB201807325D0 (en) Compositions and methods
IL254897A0 (en) Mixtures containing carotenoids and their uses
GB201502002D0 (en) Uses and compositions
GB201608762D0 (en) Compositions and uses thereof
HK1245113A1 (zh) 藥物組合物及其用途
GB201502026D0 (en) Uses and compositions
GB201501991D0 (en) Uses and compositions
ZA202004533B (en) Skin-brightening compositions and methods
IL273967A (en) Aqueous preparations containing bilastin and methotrexate
PL3568203T3 (pl) Związki i kompozycje
SG11201803025VA (en) Compositions comprising vitamins and their use
GB201614897D0 (en) Compositions and uses thereof
GB201911959D0 (en) Immunogenic compositions and uses therefor
GB201602409D0 (en) Compositions and uses thereof
GB201522814D0 (en) Compositions and uses thereof
GB201511886D0 (en) Uses and compositions
GB201812952D0 (en) Compositions and uses thereof
ZA201903341B (en) Pharmaceutical compositions and uses thereof
SG11202004167XA (en) Immunogenic compositions and uses therefor
IL252660B (en) Compounds characterized by an inverse freezing property and their uses
GB201715730D0 (en) Chitin-chitosanhydrogel compositions and their uses
GB201713920D0 (en) Pharmaceutical compositions and uses thereof